Anzeige
Mehr »
Login
Dienstag, 12.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Wir entschlüsseln die 55 $ pro Aktie Clean-Energy-Chance für SIE!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
453 Leser
Artikel bewerten:
(2)

Lakemore Partners Appoints Paul Gyra as Chair of Audit Committee

Finanznachrichten News

PHOENIX and LONDON and DUBAI, United Arab Emirates, Aug. 10, 2022and its group entities ("Lakemore"), a leading private credit investment firm primarily investing in control CLO equity, today announced it has appointed Paul Gyra as the independent Chair of the Lakemore Partners Audit Committee. Mr. Gyra is a seasoned business executive with over three decades of experience in investment banking and asset management.

"We are thrilled to have appointed Paul as Chair of our Audit Committee," said Ahmed Farid, Chairman and President of Lakemore. "Paul's deep understanding of our firm's culture and years of expertise spearheading cross-border strategies will serve Lakemore well as we further establish and maintain longstanding partnerships with our clients and top-tier CLO collateral managers across the world."

In addition to his roles at Lakemore, Mr. Gyra also serves as Managing Partner at the Thompson Family Office, where he helps to execute on the development of Smart, Sustainable City outside of Washington, DC, and development of direct investment programs with like-minded Family Office Partners that have a social and environmental impact. Previously, Mr. Gyra served as Managing Partner at Global Investment Bank Limited, where he was responsible for cross-border transactions and business development. Prior to that, Mr. Gyra was the Chief Operating Officer, Head of Strategy and Managing Partner at Safanad Limited, where he was responsible for the principal investment firm's business operations and strategy across its Dubai, New York and London offices. Mr. Gyra also held CEO positions at ING Alternative Asset Management in New York, and Baring Asset Management - North America.

"I am confident that my familiarity with the firm will serve me well in this new role," said Mr. Gyra. "I look forward to continuing to work closely with the team and Board to provide Lakemore's global clientele of institutional investors with best-in-class service."

Mr. Gyra is a CPA and received his BS Summa Cum Laude from Providence College, and attended the Advanced Management Program at Harvard Business School.

About Lakemore Partners

Lakemore is a leading private credit investment firm primarily investing in control CLO equity. Serving as a partner of choice for global top-tier collateral managers in the CLO market who are aligned to the firm's portfolio management style and risk appetite, Lakemore aims to deliver attractive returns by leveraging the extensive expertise of its dedicated team and by investing within its well-defined framework of cycle-aligned risk allocation. Founded in 2016, Lakemore has offices in Phoenix, London and Dubai. Lakemore's mission focuses on providing sustainable and reliable income, with the firm currently managing US$1.3 billion in credit assets under management, the majority of which is from institutional clients. For more information, please visit www.lakemore.com.

Lakemore Partners Ltd. is the group parent and is domiciled in the Cayman Islands. Lakemore Partners Management US LLC and Lakemore Partners (UK) Ltd. are registered with the U.S. Securities & Exchange Commission as investment advisers (RIA). Lakemore Partners (UK) Ltd. (FRN: 837603) is also an appointed representative of Kroll Securities Ltd. (FRN: 466588), which is authorized and regulated by the Financial Conduct Authority. Lakemore Partners (DIFC) Ltd. is regulated by the Dubai Financial Services Authority. Lakemore Partners Management US LLC, Lakemore Partners (UK) Ltd., and Lakemore Partners (DIFC) Ltd. are wholly owned subsidiaries of Lakemore Partners Ltd.

Media contacts:
Doug Allen/Josh Gerth
Dukas Linden Public Relations
lakemore@dlpr.com
+1 (646) 722-6530


© 2022 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.